Invest Now
Samco securities limited
  • Home
  • >
  • Stocks
  • >
  • Krebs Biochemicals Industries Ltd
Samco Star Rating Ads

Krebs Biochemicals Industries Ltd

₹ 0 (%)

Updated on 01-01-1970 5:30 AM

Stock Rating

Pros 0

 

Cons 7

Price Performance

  • Day's Low
  • ₹0
  • Day's High
  • ₹0
₹ 0
  • 52-w low
  • ₹0
  • 52-w high
  • ₹0
0
  • Day's open
    ₹0
  • Previous close
    ₹0
  • VWAP
    ₹0
  • Lower price band
    ₹0
  • Upper price band
    ₹0

Today's Market Action

Its last traded stock price on BSE was 89.42 down by -1.99%. The total volume of shares on NSE and BSE combined was 415 shares. Its total combined turnover was Rs 0.00 crores.

Medium and Long Term Market Action

The stock price of Krebs Biochemicals Industries Ltd is down by -100% over the last one month. It is down by -100% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 191

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Krebs Biochemicals Industries Ltd?

What is the Market Cap of Krebs Biochemicals Industries Ltd?

What is PE Ratio of Krebs Biochemicals Industries Ltd?

What is PB Ratio of Krebs Biochemicals Industries Ltd?

What is the CAGR of Krebs Biochemicals Industries Ltd?

How to Buy Krebs Biochemicals Industries Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • No Data Available

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only -25.00% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Negative operating earnings and interest coverage
    The company has a negative operating earnings and a negative Interest coverage ratio of -1.80 times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.33. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Negative Equity
    The company has a negative debt to equity ratio of -1.62. This implies that the underlying equity value of the business is 0 and the networth of equity holders is negative. For all practical purposes, this business is owned by it's debt holders leaving nothing for the equity holders.

Valuation Analysis

Margin of safety
(21/09/2024)
Stock Valuation
Green line
96
0%
0% People are bullish about Krebs Biochemicals Industries Ltd
0%
0 % People are bearish about Krebs Biochemicals Industries Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Krebs Biochemicals Industries Ltd

₹ 0 (%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon